Forbes -
30 Apr 2013 19:36
Wall Street is expecting lower profit for Teva Pharmaceutical Industries (TEVA) when the company reports its first quarter results on Thursday, May 2, 2013. Analysts are expecting earnings per share of $1.10 after the company booked a profit of $1.47 a share a year earlier.
Share this Article